UK markets closed

Ceragon Networks Ltd. (CRNT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7300+0.0400 (+1.49%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 230.37M
Enterprise value 248.82M
Trailing P/E 49.27
Forward P/E 131.58
PEG ratio (5-yr expected) 8.80
Price/sales (ttm)0.66
Price/book (mrq)1.71
Enterprise value/revenue 0.71
Enterprise value/EBITDA 8.26

Trading information

Stock price history

Beta (5Y monthly) 1.51
52-week change 351.12%
S&P500 52-week change 326.36%
52-week high 33.3800
52-week low 31.5600
50-day moving average 32.9466
200-day moving average 32.3131

Share statistics

Avg vol (3-month) 3608.69k
Avg vol (10-day) 3691.38k
Shares outstanding 585.64M
Implied shares outstanding 685.64M
Float 868.56M
% held by insiders 121.67%
% held by institutions 115.41%
Shares short (30 Apr 2024) 4680.31k
Short ratio (30 Apr 2024) 41.77
Short % of float (30 Apr 2024) 40.79%
Short % of shares outstanding (30 Apr 2024) 40.79%
Shares short (prior month 28 Mar 2024) 4481.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.32%
Operating margin (ttm)6.89%

Management effectiveness

Return on assets (ttm)5.30%
Return on equity (ttm)3.61%

Income statement

Revenue (ttm)352.27M
Revenue per share (ttm)4.15
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)N/A
EBITDA 34.79M
Net income avi to common (ttm)4.66M
Diluted EPS (ttm)0.0500
Quarterly earnings growth (yoy)-79.50%

Balance sheet

Total cash (mrq)28.78M
Total cash per share (mrq)0.34
Total debt (mrq)47.23M
Total debt/equity (mrq)34.98%
Current ratio (mrq)1.70
Book value per share (mrq)1.58

Cash flow statement

Operating cash flow (ttm)33.91M
Levered free cash flow (ttm)25.12M